Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
2.530
+0.030 (1.20%)
At close: Sep 30, 2026, 4:00 PM EDT
2.520
-0.010 (-0.40%)
After-hours: Sep 30, 2026, 5:45 PM EDT
Eledon Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Eledon Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $9.00. The average 1-year stock price forecast is 255.73% higher than the current stock price, while the lowest is $7.00 (+176.68%) and the highest is $12 (+374.31%).
Price Target: $9.00 (+255.73%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Eledon Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | May '26 | Jun '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 6 | 6 | 6 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Noble Financial | Noble Financial | Buy Reiterates $10 | Buy | Reiterates | $10 | +295.26% | Sep 23, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $8 | Buy | Maintains | $8 | +216.21% | Sep 22, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Maintains $8 | Buy | Maintains | $8 | +216.21% | Aug 14, 2026 |
| Rodman & Renshaw | Rodman & Renshaw | Buy Initiates $12 | Buy | Initiates | $12 | +374.31% | Jul 21, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.93
from -0.52
EPS Next Year
-0.77
from -0.93
EPS and Forward PE are based on non-GAAP adjusted numbers.